Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer

Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force

(2013) Heidi D. Nelson   ANNALS OF INTERNAL MEDICINE

Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

(2013) Jeanne S. Mandelblatt   ANNALS OF INTERNAL MEDICINE

Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer

(2009) So-Youn Jung et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

TNM: Therapeutically Not Mandatory

(2009) Richard J. Epstein   EUROPEAN JOURNAL OF CANCER

FAK overexpression and p53 mutations are highly correlated in human breast cancer

(2009) Vita M. Golubovskaya et al.   INTERNATIONAL JOURNAL OF CANCER

Dissecting genetic requirements of human breast tumorigenesis in a tissue transgenic model of human breast cancer in mice

(2009) M. Wu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis?

(2009) Anees B. Chagpar et al.   SURGERY

Screening caused rising incidence rates of ductal carcinoma in situ of the breast

(2008) L. N. van Steenbergen et al.   BREAST CANCER RESEARCH AND TREATMENT

Genomic Differences Between Pure Ductal Carcinoma In Situ of the Breast and that Associated with Invasive Disease: a Calibrated aCGH Study

(2008) V. V. Iakovlev et al.   CLINICAL CANCER RESEARCH

Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization

(2008) Yuxia Gao et al.   JOURNAL OF MOLECULAR MEDICINE-JMM